Specifications
Clinical-stage proteasome inhibitor that selectively inhibits the chymotrypsin-like activity of the 20S proteasome β5/LMP7 with IC50 of 36 nM/82 nM.
Info
| Purity | >99.0% (HPLC), NMR (conforms) |
| Quantity | 5 mg |
| Molecular Weight | 532.61 Da |
| Physical State | Lyophilized powder |
| Solubility | DMSO (107mg/mL); Ethanol (<1mg/mL); Water (<1mg/mL) |
| CAS No. | 935888-69-0 |
| Storage | 4°C, (-20°C Long term). The product can be shipped at room temperature. |
Reviews
There are no reviews yet.